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A sub-gene ncoding the lipoyl domain (residues I-85) of the lipoate acetyltransferase chain of the pyruvate dehydrogenase complex of Bacillus 
steurothermophi~us was over-expressed in Escherieh~a c ti. Approx. 80% of the domain was ~iipoylated but most of the remainder was correctly 
lipoylated on Lys-42 and could be reductively acetylated by the B stearothermophjZas enzyme complex. A small proportion (approx. 4%) of the 
domain carried au aberrant substituent, possibly an octanoyl group, on Lys-42. The 400 MHz ‘H NMR spectra of the lipoylated and unlipoylated 
domains were essentially identical and closely resembled that of the native lipoyl domain. 
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1. INTRODUCTION 
The 2-0~0 acid dehydrogenase complexes are among 
the most extensively studied multienzyme systems, in 
terms of both structure and mechanism (for recent 
reviews, see [l-3]). The Iipoate acyltransferase (E2) 
component is of particular importance in that it is the 
middle of 3 enzymes that must act sequentially in the 
overall reaction and also serves as the structural core 
(octahedral or icosahedral) of the complexes [4]. 
Thus far, no 2-0~0 acid dehydrogenase complex or 
E2 component has been crystallized but the elaborate 
domain-and-linker structure [l-3] of the E2 chain 
opens up another possibility for detailed structural 
analysis: determination of the structure of the separate 
domains and of the intervening segments of the E2 
polypeptide chain. We have already made progress, by 
means of NMR spectroscopy, with the linker regions of 
the E2p chain of the Escherichia coli pyruvate 
dehydrogenase (PDH) complex [5]. Similarly, we have 
demonstrated that the N-terminal lipoyl domain of the 
E2p chain of the Bacillus stearot~er~op~il~s PDH 
complex, which can be released by limited proteolysis, 
is a small folded protein with a robust tertiary structure 
16,71. 
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To facilitate further NMR work on the B. stea~ot~er- 
mophilus lipoyl domain, we have now created a sub- 
gene encoding it and succeeded in over-expressing it in 
E. coli. A sub-gene ncoding a lipoyl domain of the E. 
coli E2p chain has also been expressed in E. cofi 181. We 
demonstrate that E. coli can lipoylate the correct lysine 
residue of the foreign domain, at least in part, but that 
a small fraction (approx. 4%) of the purified domain 
carries another substituent on the lysine residue, 
possibly an octanoyl group. The 400 MHz ‘H NMR 
spectrum of the domain closely resembles that of the 
domain derived by proteolysis of the native B. 
stearotherntophilus PDH complex. 
2. MATERIALS AND METHODS 
2.1. Bacterial growth, genetic manipulation and DNA sequencing, 
reductive acety~ati~n 
E. coli strain TGl rec0 [9] was used as host for the various 
plasmids. Plasmid pBst42 carries the Ela! and El,8 genes and the 
beginning of the E2p gene from B. stearothermophilus 191. Cells were 
grown on 2 x TY medium [lo], supplemented with lOpg/ml lipoic 
acid and 100 pg/ml ampicillin, where applicable. Restriction enzymes 
were used as recommended by the suppliers (Amersham. Boehringer 
Mannheim, BRL). DNA sequence was determined by the dideoxy 
chain termination method [lI,12] using the Sequenase kit (US 
Biochemical) and [cu-‘%]dATP (Amersham). The mutagenic 
oligonucleotide was synthesized by Mr M. Weldon on a Milligen 
BioSearch Cyclone synthesizer and purified by ion-exchange 
chromatography 1131. Mutagenesis was performed by the 
phosphorothioate method [14, IS] using the Amersham kit. The abili- 
ty of the free lipoyl domain to become reductively acetylated by the 
PDH complex in the presence of [2-‘%]pyruvate was assayed accor- 
ding to Packman et al. [6]. 
2.2. Protein chemical methods 
Samples were reduced with 13 mM DTT (60 min) and alkylated 
with vinyl pyridine (44 mM) in 0.5 M Tris-HCI, pH 8.5, containing 
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6 M guanidine-HCI under Ar at 22°C. After 3 h, the alkylated pro- 
teins were purified by a gradient (O-64% over 30 ruin) of CHsCN in 
0.1% TFA on an Aquapore RP300 column (4.6 mm x 30 mm, 
0.3 ml/mm) using a Hewlett Packard IO9OM liquid chromatograph. 
P~idylethylated protein was coflected, dried and digested with 
S?aphylococcus aureus V8 proteinase (lqo, w/w) at 37°C for 18 h in 
1% NH4HCOs. Peptides were separated on a Spherisorb 0DS2 col- 
umn (3 mm x 100 mm) using the conditions described above. Diode 
array analysis was used to detect pyridylethylated peptides at 
245-260 nm. Peptides were characterized by amino acid analysis [7] 
and sequenced on an Applied Biosystems 477A Protein Sequencer. 
Ion-exchange chromatography of the domains was performed on a 
Polypore DEAE column (2.1 mm x 30 mm) equilibrated with 
10 mM NH4HCOs at 0.2 ml/mitt; elution of protein was by a gra- 
dient of O-O.2 M NH&K03 (5 min), then 0.2-0.4 M NI&HCOs 
(15 min). Samples of domain which were reduced (5 mM DTT, 2 h) 
and alkylated (25 mM vinyl pyridine, 2 h) in 10 mM Tris-HCl, pH 
8.3, under Ar, at 22”C, were applied directly to the column. Intact 
domains were analysed on an Applied Biosystems 270A capillary 
electrophoresis apparatus (monitoring AZ& in 0.1 M HsP04 at 
IS-20 kV and 30°C. 
2.3. Mass spectrometry and ‘H NMR spectroscopy 
FAB-mass spectrometric analysis of peptides was performed in a 
thioglycerol matrix. Samples of intact domain (250 pmol) were 
analysed by electrospray mass spectrometry on a prototype VG Bio 
Q instrument in lop1 of 2% acetic acid in 50% methanol. ‘H NMR 
spectra were recorded at 400 MHz using a Bruker AM400 WB spec- 
trometer. The lipoyl domains were freeze-dried and dissolved in *Hz0 
twice. Apparent pD was adjusted to 5.1 by adding ‘HCl, and NaN3 
was added to 0.02% (w/v). Final concentration of the samples 
(0.5 ml) was 10 mM. Spectra were recorded with quadrature detec- 
tion, a 5.5 kHz spectral width, pulse intervals of 1.5 s and presatura- 
tion of the HDO line. Before Fourier transformation, a Gaussian 
function multiplication was applied, leading to a line broadening of 
-1 Hz. 
3. RESULTS AND DISCUSSION 
3.1. Co~st~ction and expression of a sub-gene 
encoding the lipoyl domain 
A 378 bp DraI fragment from pBst49 [9] which com- 
prised the translation start and the first 86 codons of 
the B. stearothermophi~~s E2p gene was purified and 
ligated into the SmaI site of the pBSTNAV vector [ 131. 
The resulting plasmid, pBlip, carries the truncated E2 
gene under the control of the strong constitutive lpp 
promoter from E. coli. A stop codon (UAA) was in- 
troduced after codon 86 of the E2 sub-gene by directed 
mutagenesis, using the oligonucleotide 
5 ’ -CAGCAGCTGTCAAAACGTCATG-3 ’ and 
single-stranded pBlip DNA. The resulting mutant 
plasmid, pBlipS, was characterized by completely se- 
quencing its insert. It encodes exactly the lipoyl domain 
of 85 residues released by chymotryptic digestion of B. 
stearothermophilus PDH complex [7]. Crude cell ex- 
tracts of E. cofi strain TGlrecO carrying pBlipS show- 
ed an over-produced polypeptide band of Mr approx. 
9500 on SDS polyacrylamide gel electrophoresis [6], as 
expected for the lipoyl domain. 
3.2. ~ri~~at~on of the o’er-expressed Iipoyl domain 
Strain TGlrecO/pBlipS was grown in a 15 litre 
fermenter in 2 x TY medium supplemented with lipoic 
acid (10 mg/l) and glucose (0.2% w/v). Cells harvested 
in late log phase (A650 14.0, 227 g wet weight) were 
resuspended in 250 ml buffer A (20 mM Na-phosphate, 
pH 7.0; 2.7 mM EDTA; 0.02% NaN3). In all subse- 
quent steps, the presence of the lipoyl domain was 
monitored by SDS polyacrylamide gel electrophoresis 
[6]. The cells were disrupted with a French press and 
cell debris were removed by centrifugation (3 h, 16000 
x g). Nucleic acids were precipitated with streptomycin 
(3% w/v). The extract was then fractionally 
precipitated with ~monium sulphate and the 40-70% 
cut was resuspended in a minimal amount of buffer A 
(final vol. 220 ml). This extract was gel filtered, in bat- 
ches of 40 ml, on a G50 Superfine column (75 cm x 
2 cm, 24 ml/h), equilibrated with buffer A. The lipoyl 
domain eluted after the bulk of the proteins, as judged 
by the reductive acetylation assay. This indicated that 
the lipoyl domain from B. stearothermophilus was at 
least partly lipoylated by the E. coii lipoylation system. 
The samples pooled from the G50 columns (250 ml) 
were further fractionated by chromatography on a 
DE52 column (7 x 2 cm, 50 mM to 500 mM Na- 
phosphate, pH 7.0, 100 ml, 60 ml/h). The ability to 
become reductively acetylated did not coincide exactly 
with the protein peak, which exhibited a shoulder. This 
suggested that at least two overlapping forms of the 
lipoyl domain were present, only one of which could 
become reductively acetylated. The separation was im- 
proved by repeating the DE52 step, using a shallower 
gradient (200 mM to 450 mM Na-phosphate, pH 7.0, 
100 ml). The amino acid compositions and N-terminal 
sequences (10 residues) matched those of the lipoyl do- 
main isolated from the PDH complex [6,7]. The final 
yield was 290 mg of the non-acetylatable form and 
60 mg of the acetylatable form. The A$$!” of each was 
0.54. 
3.3. Characterization of the purified domains 
When examined by capillary electrophoresis, the 
acetylatable form of the lipoyl domain was found to 
contain less than 3% of the non-acetylatable form. No 
contamination of the non-acetylatable form was evi- 
dent (data not shown). Both forms of the domain were 
reduced and alkylated with vinyl pyridine under 
denaturing conditions, digested with S. aureus V8 pro- 
teinase, and the products separated by HPLC (Fig. 1). 
The peaks highlighted in profiles I (non-acetylatable 
domain) and II (acetylatable domain) were identified 
by amino acid composition and sequence analysis. 
Peak A of profile I was VQNDKAVVE, derived from 
the usual site of lipoylation (Lys-42) in the lipoyl do- 
main; this peak is clearly absent from profile II. Profile 
II, in turn, has a peak (B) which is absent from profile 
I. Peak B was VQNDXAVVE where X, based on the 
amino acid composition, must represent a modified 
derivative of lysine; its PTH-derivative eluted well after 
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Fig. 1. Reverse-phase HPLC of S. aweus V8 proteinase digests of 
alkylated lipoyl domain on Spherisorb 0DS2. Profile I, digest of 
non-acetyiatable domain; Profile II, digest of acetyiatable domain. 
Numbers above each peak denote the sequence position of the 
peptide [7] determined from amino acid and/or sequence analysis. 
PTH-Leu on an extended gradient. Sequence analysis 
of a reduced and alkylated model peptide 
TVEGD(lipoyl)KASME [ 161 showed the PTH- 
derivative of residue X in the ~aciil~~ sequence to co- 
chromatograph with that of the alkylated lipoyl-lysine 
of the model compound. FAB-mass spectrometric 
analysis of the model peptide confirmed the lipoyl 
group to be ~,~-(bis)pyridylethylated. Surprisingly, 
the peptide VQND(lipoyl)KAVVE was only detectable 
in its bis-pyridylethylated form; it could not be located 
in any part of the HPLC effluent unless the lipoyl 
group was alkylated. This property was not shared by 
the model peptide TVEGD(lipoyl)KASME, which is 
readily isolated on this reverse-phase support. The re- 
maining peaks in profiles I and II were identified as 
shown in Fig. 1. The acetylatable form of the domain 
evidently carries a lipoyl group at position Lys-42 and 
Lys-42 appears fully substituted. Similarly, Lys-42 in 
the non-acetylatable form of the domain is un- 
substituted. 
When examined by high-performance ion-exchange 
chromatography, the unlipoylated domain gave a single 
peak and its retention time was unaffected by reduction 
and alkylation with vinyl pyridine, indicating that its 
single cysteine residue, Cys-36, is not available for reac- 
tion in the folded protein. However, the reduced 
lipoylated domain gave two principal peaks. After 
subsequent alkylation with vinyl pyridine, the major 
component (80%) of the doublet moved to a higher 
position in the gradient. This was puzzling because the 
modified domain has acquired 2 extra positive charges 
and would therefore be expected to elute earlier in the 
gradient. Other interactions must increase the retention 
time of the domain. The minor component (18%) was 
unaffected (Fig. 2) and diode array analysis showed it 
not to be pyridylethylated. Given that the lipoylated 
domain preparation possessed no unsubstituted Lys-42 
(see above), the minor component must be carrying a 
substituent different from lipoic acid. 
Fig. 2. Ion-exchange chromatography of lipoylated and unlipoylated 
domain preparations on Pofypore DEAF. Lipoylated domain before 
(A) and after (B) alkylation with vinyl pyridine. Unlipoylated domain 
before (C) and after (D) alkylation with vinyl pyridine. 
3.4. An alternative to lipoylation 
Electrospray-mass spectrometry (Fig. 3) of the 
lipoylated domain preparation gave a major compo- 
nent (78~0) of 9457.5 f 1.5 Da, as expected of the 
lipoylated domain (talc. mass 9457.6 Da); a second 
component (17%) of 9395.9 f 1.9 Da; and a minor 
component (5070) of 9269.1 + 1.3 Da, corresponding to 
the low level of unlipoylated domain (talc. mass 
9269.6 Da) already detected in the preparation, The 
unlipoylated domain preparation gave a single compo- 
nent of 9269.5 & 1.8 Da, consistent with its known 
purity. The second component in the lipoylated domain 
preparation must be carrying a substituent on Lys-42 
that is uncharged and released by acid hydrolysis. The 
estimated mass of the substituent is 126.8 Da; an ob- 





Fig. 3. Electrospray-mass spectrometry of (1) lipoylated domain and 
(2) unlipoylated domain preparations. A-series, 9269.5 Da (no lipoyl 
group); B-series, 9395.9 Da (putative octanoyl domain); C-series, 
9457.5 Da (lipoyl domain). Numbers in each series denote the 
positive-charge state of each ion. 
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Fig. 4. 400 MHz ‘H NMR spectra of the isolated domains. The spectra were recorded at 45°C and are the sum of 128 transients. Top trace, 
unlipoylated lipoyl domain; bottom trace, lipoylated lipoyl domain. The chemical shifts are expressed relative to the internal trimethylsilyl 
propionate. 
127.2 Da), given that octanoic acid is a biosynthetic 
precursor of lipoic acid [ 17, IS], but this remains to be 
proven. 
3.5. ‘H NMR spectroscopy of the purified domains 
The 400 MHz ‘H NMR spectra of the lipoylated and 
un-lipoylated domains are essentially identical to each 
other (Fig. 4) and to that of the lipoyl domain released 
from the intact PDH complex by proteolytic cleavage 
[6]. The high field methyl and the aromatic proton 
resonances are particularly well conserved and stable 
over a wide temperature range (lo-65’(Z), indicating a 
well-defined tertiary structure. 2D-COSY spectra of the 
two forms are identical (data not shown), apart from a 
few additional cross-peaks in the spectrum of the 
lipoylated form which can be assigned to the lipo~ide 
moiety. 
3.6. Conclusions 
The lipoyl domain of the B. stearothermophilus E2p 
chain can now be isolated in large amounts, sufficient 
for ZD-NMR spectroscopy, from E. co& cells 
transformed with pBlipS. It is essentially identical to 
the domain obtained by limited proteolysis of the 
native PDH complex [6]. It is of particular interest hat 
E. coli cells can correctly lipoylate the B. stearother- 
mophilus domain, at least in part. Presumably the non- 
lipoylated form arises from an inability of the host E. 
coli cells to process the large amounts of domain 
emanating from the highly expressed sub-gene. The 
small amount of Iipoyl domain carrying another substi- 
tuent on the target lysine residue, very likely an oc- 
tanoyl group, may arise similarly. Whether any 
incorrect substitution of the target lysine residue of 
native E. coli lipoyl domains takes place remains to be 
investigated. 
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